Antidepressant-like effect of PRE-084, a selective σ1 receptor agonist, in Albino Swiss and C57BL/6J mice
Tóm tắt
PRE-084, a selective σ receptor agonist, exhibited an antidepressant-like effect in the forced swim test (FST) in Albino Swiss and C57BL/6J mice. This effect was counteracted by BD 1047 (5 and 10 mg/kg) but not by SM-21 (3 and 10 mg/kg), which are σ1 — and σ2-receptor antagonists, respectively. The results indicated that PRE-084 has an antidepressant-like effect in C57BL/6J and, to a lesser extent, in Albino Swiss mice. These results support the idea that σ1-receptors, but not σ2-receptors, contribute to the mechanism of antidepressant activity of σ agonists in FST.
Tài liệu tham khảo
Bermack JE, Debonnel G: The role of sigma receptors in depression. J Pharmacol Sci, 2005, 97, 317–336.
David DJ, Renard CE, Jolliet P, Hascoët M, Bourin M: Antidepressant-like effects in various mice strains in the forced swimming test. Psychopharmacology (Berl), 2003, 166, 373–382.
Debonnel G, de Montigny C: Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: possible implications for the treatment of psychiatric disorders. Life Sci, 1996, 58, 721–734.
Duman RS: Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med, 2004, 5, 11–25.
Ghelardini C, Galeotti N, Bartolini A: Pharmacological identification of SM-21, the novel σ2 antagonist. Pharmacol Biochem Behav, 2000, 67, 659–662.
Guitart X, Codony X, Monroy X: Sigma receptors: biology and therapeutic potential. Psychopharmacology (Berl), 2004, 174, 301–319.
Martin WR, Eades CG, Thompson JA, Huppier E, Gilbert PE: The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther, 1976, 197, 517–532.
Matsumoto RR, Bowen WD, Tom MA, Vo VN, Truong DD, De Costa BR: Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism. Eur J Pharmacol, 1995, 280, 301–310.
Matsumoto RR, Pouw B, Mack AL, Daniels A, Coop A: Effects of UMB24 and (±)-SM 21, putative σ2-preferring antagonists, on behavioral toxic and stimulant effects of cocaine in mice. Pharmacol Biochem Behav, 2007, 86, 86–91.
Matsuno K, Kobayashi T, Tanaka MK, Mita S: σ1 Receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test. Eur J Pharmacol, 1996, 312, 267–271.
Maurice T, Phan VL, Urani A, Kamei H, Noda Y, Nabe-shima T: Neuroactive neurosteroids as endogenous effectors for the sigmal (σ1) receptor: pharmacological evidence and therapeutic opportunities. Jpn J Pharmacol. 1999, 81, 125–155.
Phan VL, Urani A, Romieu P, Maurice T: Strain differences in σ1 receptor-mediated behaviours are related to neurosteroid levels. Eur J Neurosci, 2002, 15, 1523–1534.
Porsolt RD, Bertin A, Jalfre M: Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther, 1977, 229, 327–236.
Rogóż Z, Skuza G, Legutko B: Repeated co-treatment with fluoxetine and amantadine induces brain-derived neurotrophic factor gene expression in rats. Pharmacol Rep, 2008, 60, 817–826.
Sabino V, Cottone P, Parylak SL, Steardo L, Zorrilla EP: Sigma-1 receptor knockout mice display a depressive-like phenotype. Behav Brain Res, 2009, 198, 472–476.
Sánchez C, Meier E: Behavioural profile of SSRIs in animal models of depression, anxiety and aggression. Are they all alike? Psychopharmacology, 1997, 129, 197–205.
Skuza G: Potential antidepressant activity of sigma ligands. Pol J Pharmacol, 2003, 55, 923–934.
Skuza G, Rogóż Z: Antidepressant-like effect of combined treatment with selective sigma receptor agonists and a 5-HT1A receptor agonist in the forced swimming test in rats. Pharmacol Rep, 2007, 59, 773–777.
Su TP, Wu XZ, Cone EJ, Shukla K, Gund TM, Dodge AL, Parish DW: Sigma compounds derived from phencyclidine: identification of PRE-084, a new, selective sigma ligand. J Pharmacol Exp Ther, 1991, 259, 543–550.
Takebayashi M, Hayashi T, Su TP: Nerve growth factor-induced neurite sprouting in PC12 cells involves σ-1 receptors: implications for antidepressants. J Pharmacol Exp Ther, 2002, 303, 1227–1237.
Tran TT, de Costa BR, Matsumoto RR: Microinjection of sigma ligands into cranial nerve nuclei produces vacuous chewing in rats. Psychopharmacology (Berl), 1998, 137, 191–200.
Urani A, Roman FJ, Phan VL, Su TP, Maurice T: The antidepressant-like effect induced by σ1-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test. J Pharmacol Exp Ther, 2001, 298, 1269–1279.
Volz HP, Stoll KD: Clinical trials with sigma ligands. Pharmacopsychiatry, 2004, 37, Suppl 3, S214–220.
Wang J, Mack AL, Coop A, Matsumoto RR: Novel a receptor agonists produce antidepressant-like effects in mice. Eur Neuropsychopharmacol, 2007, 17, 708–716.
Yagasaki Y, Numakawa T, Kumamaru E, Hayashi T, Su TP, Kunugi H: Chronic antidepressants potentiate via sigma-1 receptors the brain-derived neurotrophic factor-induced signaling for glutamate release. J Biol Chem, 2006, 281, 12941–12949.